Venous thromboembolism in adults: summary of updated NICE guidance on diagnosis, management, and thrombophilia testing
Terry McCormack, Marie C. Harrisingh, Daniel Horner, Susan Bewley
Abstract
Venous thromboembolic (VTE) disease is a continuing global health burden with serious mortality, morbidity, and health economic consequences.1 The one year case fatality rate of definite or probable VTE has been estimated at 23%.2 Approximately 1 to 2 of every 1000 adults in the worldwide population will be diagnosed with VTE annually, with higher incidence rates in those over 70 (2 to 7/1000) and over 80 (3 to 12/1000).13
Topics & Concepts
NiceMedicineExcellenceGuidelineThrombophiliaVenous thromboembolismPopulationIncidence (geometry)Intensive care medicineFamily medicinePediatricsSurgeryEnvironmental healthThrombosisPolitical scienceLawPathologyProgramming languagePhysicsOpticsComputer scienceVenous Thromboembolism Diagnosis and ManagementDiagnosis and Treatment of Venous DiseasesAcute Myocardial Infarction Research